ESR1 Variants and Subcontinental Genomic Ancestry: Insights from the 1000 Genomes Project and Native American Populations
Clinical Pharmacology & Therapeutics · 2025
DOI: 10.1002/cpt.3681 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Pharmacology & Therapeutics, 2025. Verfasst von Mariana M Scudeler und 11 weiteren Autor:innen. Beteiligte Einrichtung: Pathology, Genetics and Evolution Department, Biological and Natural Sciences Institute, Federal University of Triângulo Mineiro, Uberaba, Brazil. Hauptthemen laut MEDLINE: Breast Neoplasms, Estrogen Receptor alpha. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Fundação de Amparo à Pesquisa do Estado de Minas Gerais.
Abstract (Originalsprache)
The ESR1 gene is relevant in breast cancer treatments in the pharmacogenetics context. However, Native, African, and mixed populations are known to be underrepresented in genomic studies. This is particularly important given that the difference in variants' frequencies among different populations can lead to population‐specific clinical implications. Therefore, this study aims to infer the genomic subcontinental ancestry and allele frequencies of the ESR1 gene variants in 2,427 individuals from 26 populations worldwide from the 1000 Genomes Project and 125 Natives from Peru, whose genomes have not yet been analyzed in the literature regarding this gene. Linear regression with Bonferroni correction analyses was conducted based on ancestry inference and frequencies. Our findings demonstrate subcontinental differentiation of African, Asian, European, and Native populations. Overall, 102 associations ( P < 0.01) were found for 68 clinically relevant variants. Particularly, subcontinental associations were observed for variants associated with the Native, Asian, European, and African components. We highlight the findings for the rs9340799 and rs2234693 variants, previously associated with altered responses to breast cancer treatments. rs9340799 was positively associated with the South‐Asian component, while rs2234693 was negatively associated with the Coast/Amazonian Native and positively associated with the East‐African component. Nearly half of the variants are intronic, highlighting the importance of studying whole genomes rather than just exomes. These results emphasize subcontinental differences' relevance for designing pharmacogenetic panels. Including neglected populations in genomic and pharmacogenomic studies is essential for democratic access to scientific advances and for more egalitarian and effective pharmacogenetic implementation, tailored to each population's specificities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Pathology, Genetics and Evolution Department, Biological and Natural Sciences Institute, Federal University of Triângulo Mineiro, Uberaba, Brazil.
- Genetics, Ecology and Evolution Department, Biological Sciences Institute, Federal University of Minas Gerais, Belo Horizonte, Brazil.
- Laboratório de Innovación y Desarrollo, Instituto Nacional de Salud, Lima, Peru.
- Universidad de Huanuco, Huanuco, Peru.
- Institute for Genomes Sciences, University of Maryland School of Medicine, Baltimore, Maryland, USA.
- Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
ORCID-Profile: Mariana M Scudeler, Caíque Manóchio, Bruno Miwa, Guilherme Belfort-Almeida, Lucas Faria-Costa, Eduardo Tarazona-Santos, Fernanda Rodrigues-Soares
Förderung
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
- Fundação de Amparo à Pesquisa do Estado de Minas Gerais
- Brazilian Ministry of Health
- Instituto Nacional de Salud, Peru
- Ministério da Saúde
- Instituto Nacional de Salud
Zitieren
APA
Scudeler, M. M., Manóchio, C., Miwa, B., Belfort-Almeida, G., Faria-Costa, L., Sanchez, C., Padilla, C., Caceres, O., Tarazona-Santos, E., Guio, H., O'Connor, T. D., & Rodrigues-Soares, F. (2025). ESR1 Variants and Subcontinental Genomic Ancestry: Insights from the 1000 Genomes Project and Native American Populations. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.3681
Vancouver
Scudeler MM, Manóchio C, Miwa B, Belfort-Almeida G, Faria-Costa L, Sanchez C, et al. ESR1 Variants and Subcontinental Genomic Ancestry: Insights from the 1000 Genomes Project and Native American Populations. Clinical Pharmacology & Therapeutics. 2025. doi:10.1002/cpt.3681
BibTeX
@article{Scudeler2025,
author = {Scudeler, Mariana M and Manóchio, Caíque and Miwa, Bruno and Belfort-Almeida, Guilherme and Faria-Costa, Lucas and Sanchez, Cesar and Padilla, Carlos and Caceres, Omar and Tarazona-Santos, Eduardo and Guio, Heinner and O'Connor, Timothy D and Rodrigues-Soares, Fernanda},
title = {ESR1 Variants and Subcontinental Genomic Ancestry: Insights from the 1000 Genomes Project and Native American Populations},
journal = {Clinical Pharmacology & Therapeutics},
year = {2025},
doi = {10.1002/cpt.3681}
}
EUVIMED